Clinical Trial Update: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ABX464 assessing long-term safety and efficacy in moderate to severe active ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ABX464 (ABX464)

Snippet

Sponsor: Abivax S.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING